Nyumbani › Saratani ya Mkojo › Ohio › Cincinnati
Majaribio ya kliniki ya Saratani ya Mkojo katika Cincinnati, OH
Masomo 10 ya Saratani ya Mkojo yanatafuta washiriki katika vituo vya Cincinnati na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- na zaidi ya 3
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
InaajiriHatua 2
- TriState Urologic Services PSC Inc. dba The Urology Group ( Site 0122), Cincinnati
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
InaajiriHatua 2
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · Mi 15 mbali
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
InaajiriHatua 3
- Oncology Hematology Care Clinical Trials, LLC, Fairfield · Mi 15 mbali
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
InaajiriHatua 3
- TriHealth Cancer Institute-Good Samaritan Hospital ( Site 0822), Cincinnati
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
InaajiriHatua 3
- University of Cincinnati Medical Center, Cincinnati
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
InaajiriHatua 2
- The Urology Group (Solaris), Cincinnati
- University of Cincinnati Cancer Center, Cincinnati
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
InaajiriHatua 1
- University of Cincinnati Medical Center (UCMC), Cincinnati
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
InaajiriHatua 1/2
- University of Cincinnati Medical Center, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
InaajiriUtafiti wa uchunguzi
- Massive Bio SYNERGY-AI site, Cincinnati
Majaribio ya Saratani ya Mkojo katika miji mingine
- New York City, NYUtafiti 35
- Nashville, TNUtafiti 31
- Houston, TXUtafiti 31
- Dallas, TXUtafiti 27
- Boston, MAUtafiti 26
- Washington, DCUtafiti 26
- Los Angeles, CAUtafiti 24
- Baltimore, MDUtafiti 24
- St. Louis, MOUtafiti 22
- Philadelphia, PAUtafiti 21
- Seattle, WAUtafiti 21
- Edison, NJUtafiti 21
Masomo mengine katika Cincinnati
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 35
- Saratani (aina zote)Utafiti 27
- Saratani ya MatitiUtafiti 25
- Kushindwa kwa MoyoUtafiti 24
- Kansari ya kolorektaliUtafiti 21
- Leukemia ya Myeloid ya GhaflaUtafiti 20
- Saratani ya MetastasiUtafiti 20
- Kansari ya MayaiUtafiti 19
- Saratan ya MapafuUtafiti 19
- UnenepuUtafiti 19
- Saratani ya ProstateUtafiti 18
- Multiple MyelomaUtafiti 17
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.